Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (421-430 of 461) with videos related to

Pageof 47
Sort By:
Psychiatry Research|September 13, 2025
Decreased long-interval intracortical inhibition in the dorsolateral prefrontal cortex using TMS-EEG in patients with treatment-resistant depressionMayuko Takano, Masataka Wada, Shinichiro Nakajima, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Psychiatric Research|February 15, 2025
Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI studyKoki Takahashi, Yoshihiro Noda, Nobuaki Hondo, et al.
Journal of Neuropathology and Experimental Neurology|February 14, 2026
Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratificationNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Brain Tumor Pathology|April 6, 2025
Analysis of clinical, histological, and genomic information of molecular glioblastoma in a Japanese glioma cohortRyutaro Makino, Madan Bajagain, Nayuta Higa, et al.
Neuro-Oncology Advances|August 2, 2023
Favorable prognostic impact of <i>phosphatase and tensin homolog</i> alterations in wild-type isocitrate dehydrogenase and <i>telomerase reverse transcriptase</i> promoter glioblastomaNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Psychiatry Research. Neuroimaging|May 2, 2026
Brain iron-sensitive markers (magnetic susceptibility and R2*) predict antidepressant response to ketamine in treatment-resistant depressionKengo Yonezawa, Shinichiro Nakajima, Shuhei Shibukawa, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 8, 2023
Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRIKiyohisa Kamimura, Yoshiki Kamimura, Tsubasa Nakano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2019
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyRyosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2020
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyRyo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, et al.
Pageof 47

Showing results (421-430 of 461) with videos related to

Sort By:
Pageof 47
Psychiatry Research|September 13, 2025
Decreased long-interval intracortical inhibition in the dorsolateral prefrontal cortex using TMS-EEG in patients with treatment-resistant depressionMayuko Takano, Masataka Wada, Shinichiro Nakajima, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Psychiatric Research|February 15, 2025
Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI studyKoki Takahashi, Yoshihiro Noda, Nobuaki Hondo, et al.
Journal of Neuropathology and Experimental Neurology|February 14, 2026
Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratificationNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Brain Tumor Pathology|April 6, 2025
Analysis of clinical, histological, and genomic information of molecular glioblastoma in a Japanese glioma cohortRyutaro Makino, Madan Bajagain, Nayuta Higa, et al.
Neuro-Oncology Advances|August 2, 2023
Favorable prognostic impact of <i>phosphatase and tensin homolog</i> alterations in wild-type isocitrate dehydrogenase and <i>telomerase reverse transcriptase</i> promoter glioblastomaNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Psychiatry Research. Neuroimaging|May 2, 2026
Brain iron-sensitive markers (magnetic susceptibility and R2*) predict antidepressant response to ketamine in treatment-resistant depressionKengo Yonezawa, Shinichiro Nakajima, Shuhei Shibukawa, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 8, 2023
Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRIKiyohisa Kamimura, Yoshiki Kamimura, Tsubasa Nakano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2019
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyRyosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2020
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyRyo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, et al.
Pageof 47